Edris Hoseinzadeh | Developmental Neuroscience | Best Researcher Award

Assoc. Prof. Dr.Edris Hoseinzadeh | Developmental Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Edris Hoseinzadeh | Saveh University of Medical Sciences | Iran

Dr. Edris Hoseinzadeh is an Associate Professor of Environmental Health Engineering at Saveh University of Medical Sciences, Iran. He is a highly accomplished environmental health engineer recognized for his innovative research on sustainable solutions for water and wastewater treatment, air pollution control, and waste valorization. His scientific expertise spans advanced oxidation processes, electrochemical systems, nanotechnology applications, and the integration of artificial intelligence in smart remediation technologies. Dr. Hoseinzadeh has authored over 90 research papers, holds multiple patents, and has achieved an h-index of 18 with more than 2,500 citations, reflecting his significant impact in the field. His work addresses critical global challenges such as emerging contaminants, pharmaceutical pollutants, microplastics, and antibiotic-resistant genes, with a focus on resource recovery and circular economy principles. As Head of the Department of Environmental Health Engineering at Saveh University, he has also demonstrated strong leadership and academic mentorship, guiding over 15 graduate theses and serving as Founder and Editor-in-Chief of the HOZAN Journal of Environmental Sciences. Dr. Hoseinzadeh’s research combines scientific rigor with practical innovation, contributing to the advancement of environmental sustainability and public health protection.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

(2025). Factors influencing source separation intention for improving waste management in educational places: A case study for a university campus. International Journal of Environmental Health Engineering.

 (2024). Microplastics contamination in popular soft drinks and non-alcoholic beverages marketed in Iran: Quantity and characteristics. Results in Engineering.

 (2024). Soil pollution indices and health risk assessment of metal(loid)s in the agricultural soil of pistachio orchards. Scientific Reports.

 (2024). Treatment of real carwash wastewater using high-efficiency and energy-saving electrocoagulation technique. Sustainable Chemistry and Pharmacy.

(2024). Water recovery and treatment of spent filter backwash from drinking water using chemical reactor–ultrafiltration process. Journal of Water Process Engineering.

(2024). Utilization of local corn (Zea mays) wastes for bioethanol production by separate hydrolysis and fermentation. Journal of Hazardous Materials Advances.

Dongxia Zhu | Neurogenetics | Best Researcher Award

Prof. Dongxia Zhu | Neurogenetics | Best Researcher Award

Prof. Dongxia Zhu | The Northeast Normal University | China

Prof. Dongxia Zhu is a full professor in the Department of Chemistry at Northeast Normal University, specializing in functional organic and polymeric photoelectric materials and devices. She earned her Ph.D. in Chemistry under the supervision of Prof. Zhong-Min Su at NENU and pursued joint doctoral research at Jilin University under Prof. Yue Wang. She also served as an academic visitor at Durham University, UK, collaborating with Prof. Martin R. Bryce and Prof. Todd B. Marder. Prof. Zhu has conducted extensive research on the design and development of high-performance luminescent materials, leading to the creation of highly selective and sensitive fluorescent and phosphorescent probes applied in photodynamic cancer therapy, biological imaging, and luminescence sensing. She has completed 12 research projects, published 50 SCI-indexed papers, authored one book chapter, and holds 12 patents. Her scholarly work has achieved 4,574 citations across 3,698 documents, with 123 publications and an h-index of 38. Prof. Zhu is an active member of the Chinese Chemical Society, contributing significantly to advancements in luminescent materials and their biomedical and photoelectric applications.

Profile: Scopus

Featured Publications

Wang, Z., Li, Y., Zhang, H., Jiang, N., Xu, J., Zhu, D., & Bryce, M. R. (2025). Non-traditional luminescent polyurethanes of n–π electron hybrid structures with varying separation of aromatic rings. ACS Applied Polymer Materials, 7(18), 12337–12344.


Zhu, D., Chen, X., Wang, J., & Li, Q. (2025). A new strategy enabling combined fluorescence imaging of individual tuberculous granulomas and precise photothermal therapy of tuberculosis with lesion- and pathogen-targeting capabilities of the nanoparticles. Note, Open Access.


Wang, Z., Wang, W., Wu, Q., & Zhu, D. (2025). Constructing 1 + 1 > 2 photosensitizers based on NIR cyanine–iridium(III) complexes for enhanced photodynamic cancer therapy. Molecules, 30(12), 2662.


Sun, Y., Tang, Y., Zhang, L., Zhao, H., Wang, Z., & Zhu, D. (2025). Self-assembly versus coassembly: An amphiphilic NIR-II aggregation-induced emission luminogen for phototheranostics of orthotopic glioblastoma. Journal of Medicinal Chemistry.


Wang, Z., Liu, Y., Zhao, L., Tang, Y., & Zhu, D. (2025). Endogenous near-infrared chemiluminescence: Imaging-guided non-invasive thrombolysis and anti-inflammation based on a heteronuclear transition metal complex. Advanced Science, 12(5), 14567.


Wang, Z., Li, C., Zhao, H., Tang, Y., & Zhu, D. (2025). Leveraging tumor microenvironment to boost synergistic photodynamic therapy, ferroptosis anti-tumor efficiency based on a functional iridium(III) complex. Advanced Science, 12(7), 14892.


Tang, Y., Wang, Z., Zhao, H., Sun, Y., & Zhu, D. (2025). Sonodynamic and bioorthogonal sonocatalytic thrombotic therapy based on AIE cationic tetranuclear Ir(III) complex nanoplatform guided by NIR-chemiluminescence imaging. Advanced Materials, 37(4), 2310674.


Zhu, D., Wang, Z., & Tang, Y. (2025). The Midas touch by internal stimuli: Activatable luminogens with near-infrared aggregation-induced emission for potent bioimaging and theranostics. Review Article.


Wang, Z., Li, X., Zhao, H., Tang, Y., & Zhu, D. (2024). Disulfide-bridged cationic dinuclear Ir(III) complex with aggregation-induced emission and glutathione-consumption properties for elevating photodynamic therapy. Inorganic Chemistry, 63(22), 18945–18956.


Wang, Z., Tang, Y., Zhao, H., & Zhu, D. (2024). Phosphorescent sensor based on iridium(III) complex with aggregation-induced emission activity for facile detection of volatile acids. Molecules, 29(9), 2031.

Soheila Hosseinzadeh | Cognitive Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Soheila Hosseinzadeh | Cognitive Neuroscience | Best Researcher Award

Assist. Prof. Dr. Soheila Hosseinzadeh, Tehran University of Medical Sciences, Iran.

Dr. Soheila Hosseinzadeh is a distinguished Assistant Professor of Neuroscience at the Tehran University of Medical Sciences, with a rich academic background that spans nursing, physiology, and neuroscience. Over the years, she has made substantial contributions to neuroscience education and research, particularly in the fields of cognitive neurophysiology and addiction studies. Her expertise includes a wide range of advanced techniques such as event-related potential analysis, EEG-based neurofeedback, behavioral studies, and molecular tools like RT-PCR and ELISA. She has played a pivotal role in training students and developing neuroscience programs at multiple academic institutions, demonstrating a balanced commitment to both teaching and scientific innovation.

Academic Profile

Google Scholar

Early Academic Pursuits

Dr. Soheila Hosseinzadeh’s academic foundation is deeply rooted in an interdisciplinary understanding of human physiology and neurological sciences. Her early career began with a Bachelor of Science in Nursing in 2000, which was soon followed by a Master’s degree in Physiology in 2003. Demonstrating a keen interest in the mechanisms underlying brain function and behavior, she further advanced her expertise by earning a Ph.D. in Neuroscience in 2013. These academic milestones laid a solid groundwork for her future in teaching and cutting-edge neurophysiological research.

Professional Endeavors in Neuroscience

After completing her Ph.D., Dr. Hosseinzadeh embarked on an academic and research-oriented career that has spanned over a decade. From 2014 to April 2022, she served as a neurophysiology course instructor at Babol University of Medical Sciences, nurturing future scientists with her in-depth understanding of brain physiology. Since April 2022, she has continued her academic contributions at the Tehran University of Medical Sciences, where she teaches courses in Neuroscience and Addiction Studies. Her dual role as educator and researcher places her at the forefront of neuroscience education in Iran.

Contributions and Research Focus

Dr. Hosseinzadeh’s research is focused on the interface of cognitive neuroscience and addiction studies. Her technical proficiency includes advanced neurophysiological techniques such as event-related potential (ERP) recording and analysis, quantitative EEG (QEEG)-based neurofeedback, and behavioral assessments in animal models. She is also experienced in molecular biology tools including real-time RT-PCR and ELISA, alongside rodent stereotaxic surgeries and flow cytometry. Her work often explores neural mechanisms underlying cognitive functions, brain plasticity, and responses to addictive substances—bridging lab findings with clinical relevance.

Accolades and Recognition

Throughout her academic journey, Dr. Hosseinzadeh has earned recognition for her expertise in neurophysiological and behavioral science. Her dual roles at prestigious institutions such as Tehran University of Medical Sciences reflect her trusted authority in the field. While her accolades are more rooted in impact and mentorship than in public awards, her consistent engagement in neuroscience education and translational research is a clear indicator of peer acknowledgment and professional respect.

Impact and Influence

Dr. Hosseinzadeh’s influence extends beyond academic teaching. By integrating theoretical neuroscience with hands-on technical applications like neurofeedback and EEG-based cognitive training, she fosters a research culture that promotes both clinical innovation and scientific discovery. Her guidance has shaped students and young researchers in multiple universities, many of whom continue to advance the fields of neurophysiology and cognitive rehabilitation across the country.

Legacy in Neurotechnology and Cognitive Health

Her pioneering efforts in cognitive task design and ERP analysis have significantly contributed to Iran’s growing reputation in brain research. As one of the few experts integrating neurofeedback with behavioral science and electrophysiology, Dr. Hosseinzadeh has helped establish a platform for neurotechnological interventions in addiction and mental health studies. Her legacy lies in creating an interdisciplinary approach that merges neuroscientific inquiry with practical healthcare applications.

Future Contributions and Vision

Looking ahead, Dr. Soheila Hosseinzadeh is poised to make even greater strides in neuroscience, particularly in the domains of addiction neurobiology, cognitive rehabilitation, and neurofeedback therapy. With continuous advancements in brain-monitoring tools and behavioral modeling, she aims to lead research projects that offer deeper insights into brain-behavior relationships and provide innovative treatments for neuropsychiatric disorders. Her vision includes developing collaborative research networks that connect Iranian neuroscience to global scientific conversations.

Publication

Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus
M Khalili-Fomeshi, MG Azizi, MR Esmaeili, M Gol, S Kazemi, …
2018

Plasma microparticles in Alzheimer’s disease: The role of vascular dysfunction
S Hosseinzadeh, M Noroozian, E Mortaz, K Mousavizadeh
2018

Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment
S Hosseinzadeh, M Zahmatkesh, MR Zarrindast, GR Hassanzadeh, …
2013

Effect of methamphetamine exposure on the plasma levels of endothelial-derived microparticles
A Nazari, M Zahmatkesh, E Mortaz, S Hosseinzadeh
2018

Hippocampal DHCR24 down regulation in a rat model of streptozotocin-induced cognitive decline
S Hosseinzadeh, M Zahmatkesh, M Heidari, GR Hassanzadeh, …
2015

Increment of CSF fractalkine-positive microvesicles preceded the spatial memory impairment in amyloid beta neurotoxicity
L Karimi-Zandi, M Zahmatkesh, G Hassanzadeh, S Hosseinzadeh
2022

Arbutin intervention ameliorates memory impairment in a rat model of lysolecethin induced demyelination: Neuroprotective and anti-inflammatory effects
S Ashrafpour, MJ Nasr-Taherabadi, A Sabouri-Rad, S Hosseinzadeh, …
2024

Conclusion

Dr. Hosseinzadeh’s career reflects an exemplary blend of academic excellence, technical expertise, and visionary research in neuroscience. Her efforts have significantly advanced the understanding of brain function, particularly in the context of addiction and cognitive health. As a leader in her field, she continues to inspire the next generation of neuroscientists while actively contributing to translational research that bridges laboratory findings with clinical solutions. With her ongoing work and future vision, Dr. Hosseinzadeh stands out as a key figure in shaping the future of neuroscience in Iran and beyond.

Izabela Małysz-Cymborska | Neurogenetics | Best Researcher Award

Assoc. Prof. Dr. Izabela Małysz-Cymborska | Neurogenetics | Best Researcher Award

Assoc. Prof. Dr. Izabela Małysz-Cymborska,  Department of Neurology and Neurosurgery, School of Medicine, University of Warmia and Mazury, Poland.

Dr. Izabela Małysz-Cymborska is a distinguished biomedical researcher and Associate Professor in Neurosurgery at the University of Warmia and Mazury, Poland. Her academic path began with a Master’s in Biology and culminated in a Ph.D. focused on hormonal mechanisms, followed by a Habilitation in Medicine. Her research spans neuroregeneration, stem cell therapy, and immunomodulatory strategies for neurological diseases such as ALS and stroke. She has led and contributed to nationally funded projects like NanoTech4ALS, Explore Me, and her current OPUS-funded investigation using a swine model for stroke therapy. Her interdisciplinary approach bridges molecular biology, reproductive science, and clinical neuroscience, demonstrating a rare ability to translate foundational research into therapeutic innovation.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Izabela Małysz-Cymborska embarked on her academic journey with a deep-rooted interest in biological sciences. Born on September 21, 1985, in Poland, she pursued her undergraduate studies at the University of Warmia and Mazury in Olsztyn, earning a Master of Science degree in Biology in 2009. Her passion for advanced biomedical research led her to the Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, where she completed her Ph.D. in 2015. Her doctoral research, grounded in hormonal action mechanisms, laid the foundation for her future contributions to neurobiology and regenerative medicine.

🧠 Professional Endeavors in Neuroscience

Dr. Małysz-Cymborska’s postdoctoral and professional journey has been largely rooted in neuroscientific investigation, with a special focus on neuroregeneration and stroke therapy. Since 2021, she has held the position of Associate Professor in the Department of Neurosurgery at the University of Warmia and Mazury. Her early postdoctoral fellowships (2015–2018) focused on pioneering work in the application of glial progenitors and stem cells in neurological disorders like ALS. These formative experiences not only enriched her research trajectory but also provided a vital bridge between animal studies and translational medicine.

🧪 Research Focus and Scientific Contributions

Dr. Małysz-Cymborska’s research portfolio reflects a consistent dedication to understanding complex neural pathologies and their treatment through regenerative approaches. She has led and contributed to several national and international projects, including NanoTech4ALS, which investigated MRI-monitored transplantation techniques using hydrogel carriers for ALS treatment. Her current role as Principal Investigator in the OPUS-funded project explores an endovascular model of stroke in swine, opening new therapeutic pathways for immunomodulation. She has also delved into reproductive biology, investigating the influence of gonadotropins on prostaglandin synthesis and the function of the corpus luteum, showcasing her multidisciplinary expertise.

🧬 Bridging Regeneration and Technology

A major hallmark of Dr. Małysz-Cymborska’s work is the integration of regenerative medicine and cutting-edge biomedical technologies. Her involvement in Explore Me and NanoTech4ALS demonstrated her commitment to merging cellular therapy with advanced biomaterials and imaging. These projects explored the therapeutic potential of mesenchymal stem cells and human glial progenitors for neurodegenerative conditions, reflecting her drive to push boundaries in translational medicine and neurosurgery.

🏅 Accolades and Recognition

Dr. Małysz-Cymborska’s scientific accomplishments were recognized through her Habilitation Degree in Medicine, awarded in 2022 by the University of Warmia and Mazury—a prestigious academic achievement in Poland that underscores her contributions to the medical sciences. Additionally, her appointment as the Dean’s representative for animal experiments between 2018 and 2019 further illustrates the trust and respect she commands within her institution and the research community.

🌍 Impact and Influence in Translational Neuroscience

Her work has had significant implications not only in Poland but also across the global neuroscience landscape. By focusing on models that simulate real-world human neurological disorders, such as swine models for stroke and ALS, she has established platforms that can more accurately predict treatment outcomes in humans. Her collaborative efforts within national strategic medical programs have enriched the broader field of translational neuroscience, particularly in immune response modulation and neural repair mechanisms.

🔮 Legacy and Future Contributions

As her OPUS project continues until 2025, Dr. Izabela Małysz-Cymborska is poised to deliver crucial insights into stroke immunotherapy. Her legacy lies in her ability to traverse boundaries between endocrinology, neurobiology, and regenerative therapy—crafting a unique niche that advances both fundamental science and clinical application. With a promising trajectory ahead, she is set to influence future protocols in neurovascular therapy, offering hope to patients with currently untreatable conditions.

Publication

  • Hydrogel-based scaffolds to support intrathecal stem cell transplantation as a gateway to the spinal cord: clinical needs, biomaterials, and imaging technologies
    Authors: JM Oliveira, L Carvalho, J Silva-Correia, S Vieira, M Majchrzak, …
    Year: 2018

 

  • Advances in bioinks and in vivo imaging of biomaterials for CNS applications
    Authors: EP Oliveira, I Malysz-Cymborska, D Golubczyk, L Kalkowski, …
    Year: 2019

 

  • The role of glia in canine degenerative myelopathy: relevance to human amyotrophic lateral sclerosis
    Authors: D Golubczyk, I Malysz-Cymborska, L Kalkowski, M Janowski, JR Coates, …
    Year: 2019

 

  • Methacrylated gellan gum and hyaluronic acid hydrogel blends for image-guided neurointerventions
    Authors: S Vieira, P Strymecka, L Stanaszek, J Silva-Correia, K Drela, …
    Year: 2020

 

  • MRI-guided intrathecal transplantation of hydrogel-embedded glial progenitors in large animals
    Authors: I Malysz-Cymborska, D Golubczyk, L Kalkowski, A Burczyk, M Janowski, …
    Year: 2018

 

  • Endovascular model of ischemic stroke in swine guided by real-time MRI
    Authors: D Golubczyk, L Kalkowski, J Kwiatkowska, M Zawadzki, P Holak, J Glodek, …
    Year: 2020

 

  • Expression of the vascular endothelial growth factor receptor system in porcine oviducts after induction of ovulation and superovulation
    Authors: I Małysz-Cymborska, A Andronowska
    Year: 2014

 

  • Rabbit model of human gliomas: implications for intra-arterial drug delivery
    Authors: H Qin, M Janowski, MS Pearl, I Malysz-Cymborska, S Li, CG Eberhart, …
    Year: 2017

 

  • Two in one: use of divalent manganese ions as both cross-linking and MRI contrast agent for intrathecal injection of hydrogel-embedded stem cells
    Authors: L Kalkowski, D Golubczyk, J Kwiatkowska, P Holak, K Milewska, …
    Year: 2021

 

  • Effect of hCG and eCG treatments on Prostaglandins Synthesis in the Porcine Oviduct
    Authors: I Małysz‐Cymborska, AJ Ziecik, A Waclawik, A Andronowska
    Year: 2013

 

🧾 Conclusion

Dr. Małysz-Cymborska’s career reflects a compelling fusion of scientific curiosity, clinical relevance, and academic rigor. With notable achievements in regenerative medicine and translational neuroscience, she continues to shape the future of therapeutic interventions for complex neurological disorders. Her ongoing research promises to pave the way for advanced stroke treatments and immune-based neurotherapies, cementing her role as a key contributor to modern biomedical science.

Zhenhua Wu | Neurogenetics | Distinguished Scientist Award

Dr. Zhenhua Wu | Neurogenetics | Distinguished Scientist Award

Dr. Zhenhua Wu, Exegenesis Bio, Inc ,United States.

Zhenhua Wu is a distinguished biotech entrepreneur and scientific leader with over 20 years of experience across the research and development value chain. As the founder, President, and CEO of Exegenesis Bio Inc., he has pioneered accessible, innovative gene therapies for patients with unmet medical needs. His journey spans rigorous academic beginnings, executive leadership in multiple biotechnology companies, and a steadfast commitment to global health advancement. Known for assembling world-class talent and making strategic decisions, Wu has played a key role in shaping the future of gene therapy through both scientific and business excellence.

Profile

Orcid

 

🎓 Early Academic Pursuits

Zhenhua Wu’s journey into the world of biotechnology and gene therapy was shaped by a solid academic foundation rooted in scientific rigor and innovation. During his early academic pursuits, he demonstrated a deep curiosity for biological systems and therapeutic sciences. This intellectual appetite laid the groundwork for his future endeavors in translational medicine, where scientific discovery meets real-world application. His academic training not only honed his research skills but also instilled a lifelong commitment to innovation in the life sciences.

💼 Professional Endeavors

With more than two decades of hands-on experience in the research and development value chain, Zhenhua Wu has established himself as a seasoned leader in biotechnology. He has served in executive roles across a range of biotech companies of various sizes and strategic focuses. In each capacity, he brought visionary leadership, guiding teams to deliver impactful solutions in the biomedical space. His career has been a progressive climb from scientific inquiry to corporate strategy, integrating a robust understanding of science with sharp business acumen.

🧬 Contributions and Research Focus

As a pioneer in the field of gene therapy, Zhenhua Wu’s contributions are both profound and multifaceted. He is the founder and current President and CEO of Exegenesis Bio Inc., a multinational gene therapy company based in Philadelphia, PA. Under his leadership, the company has developed a pipeline of innovative, affordable gene therapies designed to address high unmet medical needs. His research focus lies in advancing next-generation gene therapies that are not only effective but also accessible, aiming to bridge the gap between scientific breakthroughs and patient care.

🏆 Accolades and Recognition

Zhenhua Wu’s impactful career has earned him recognition as a visionary entrepreneur and scientific innovator. Though his biography remains modest in tone, his work has resonated across the biotech sector, attracting significant investment and strategic partnerships. His ability to build and lead a cutting-edge biotech company from the ground up has marked him as a key influencer in gene therapy, with accolades stemming from both industry peers and investors who recognize the value and promise of his work.

🌍 Impact and Influence

Through Exegenesis Bio, Zhenhua Wu has catalyzed a new wave of therapeutic innovation with global reach. His influence extends beyond the lab and boardroom, impacting regulatory conversations, patient advocacy movements, and international biotech development. By forging cross-continental collaborations and assembling a top-tier team of experts, he has ensured that the company is positioned as a global leader in gene therapy solutions, redefining what is possible in patient care and drug development.

🧭 Legacy and Future Contributions

Looking ahead, Zhenhua Wu continues to chart a path focused on expanding access to gene therapy on a global scale. His legacy is being built not only through the therapies under development but also through the culture of scientific integrity, innovation, and purpose that he has instilled in his company. He remains dedicated to mentoring future leaders, cultivating partnerships that push boundaries, and shaping a future where life-altering treatments are within reach for all who need them.

🧠 Visionary Leadership in Gene Therapy

At the heart of Zhenhua Wu’s professional identity is his role as a visionary leader in the fast-evolving field of gene therapy. His ability to connect scientific breakthroughs with patient-focused strategies has transformed Exegenesis Bio into a beacon of hope for countless individuals suffering from genetic diseases. Through his relentless pursuit of innovation, ethical leadership, and commitment to excellence, he continues to redefine what leadership means in the life sciences industry.

Publication

  • Title: Tunneling Nanotubes and Gap Junctions–Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions
    Authors: Ariazi J, Benowitz A, De Biasi V, den Boer M, Cherqui S, Cui H, Douillet N, Eugenin EA, Favre D, Goodman S, et al.
    Year: 2017

 

  • Title: Quantitative assessment of Aβ peptide in brain, cerebrospinal fluid and plasma following oral administration of γ-secretase inhibitor MRK-560 in rats
    Authors: Wu G, Wu Z, Na S, Hershey JC
    Year: 2015

 

  • Title: Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
    Authors: Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, et al.
    Year: 2005

 

🔚 Conclusion

Zhenhua Wu’s career reflects the powerful intersection of science, leadership, and purpose. From building a visionary biotech enterprise to steering the development of transformative therapies, his contributions continue to resonate across the scientific community and healthcare industry. His legacy is not only defined by the innovations he leads today but also by the future he is helping shape—one where advanced gene therapies are more equitable, effective, and globally impactful. Through unwavering dedication and strategic foresight, he stands as a beacon of inspiration in the world of modern biotechnology.

Elissavet Kollia | Developmental Neuroscience |Best Researcher Award

Ms. Elissavet Kollia | Developmental Neuroscience |Best Researcher Award 

Ms. Elissavet Kollia, National Kapodistrian University of Athens, Greece.

Ms. Elissavet Kollia is a distinguished pediatrician and researcher specializing in pediatric neurology. With an exceptional academic background, she graduated from the Medical School of the Democritus University of Thrace and pursued advanced postgraduate studies in Clinical Pediatrics and Nursing-Research. Her extensive clinical training, from pediatrics specialization to her current role at Konstantopouleio General Hospital “Agia Olga,” has solidified her expertise in child healthcare. Additionally, her research focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, contributing valuable insights to the field. Her dedication extends beyond clinical practice, as seen in her voluntary medical work and commitment to mentoring young professionals.

Profile

Google Scholar

🎓 Early Academic Pursuits

From an early age, Elissavet Kollia demonstrated exceptional academic abilities, graduating from the 4th General Lyceum of Agia Paraskevi with an outstanding general grade of “excellent 19.2.” Her passion for medicine led her to the Medical School of the Democritus University of Thrace, where she was admitted in September 2007. With dedication and perseverance, she successfully earned her medical degree in July 2013, achieving a commendable grade of “very good 8.33.” Shortly after, she obtained her license to practice as a doctor in Greece and later in Munich, Germany, reflecting her international medical competence.

🏥 Professional Endeavors

Ms. Kollia’s professional journey has been marked by extensive clinical training and hands-on experience in pediatrics. She began her specialization at the Pediatric Clinic of the General Hospital of Karpenisi from June 2014 to October 2016. Her commitment to healthcare extended beyond hospitals as she served as a rural doctor at the Primary Health Care Center of Agios Nikolaos, Evrytania, actively participating in emergency care at the General Hospital of Karpenisi. Her expertise deepened when she became a scientific associate at the Pediatric Neurology Unit of the First Pediatric Clinic of the National University of Athens. She then pursued her residency in pediatrics at the First University Pediatric Clinic – Children’s Hospital “Agia Sophia” from November 2018 to May 2022, ultimately obtaining her specialty title in June 2022. Currently, she is serving as a pediatrician at the Konstantopouleio General Hospital “Agia Olga,” continuing her mission to provide excellent pediatric care.

📝 Contributions and Research Focus

Ms. Kollia’s dedication to medical research has significantly contributed to the field of pediatric neurology. Her postgraduate studies in “Clinical Pediatrics and Nursing-Research,” completed with an exceptional grade of “Excellent 9.31,” strengthened her academic foundation. Her ongoing doctoral dissertation at the National Kapodistrian University of Athens focuses on movement disorders in pediatric patients with early-onset developmental and epileptic encephalopathy, a field crucial for advancing neurological care in children. Her research efforts have led to an upcoming publication in the European Journal of Paediatric Neurology, further establishing her as a valuable contributor to the scientific community.

🌟 Accolades and Recognition

Ms. Kollia’s unwavering commitment to medicine has been recognized through her outstanding academic achievements and professional milestones. From excelling in her graduate and postgraduate studies to securing prestigious residency and specialization opportunities, she has consistently demonstrated excellence in her field. Her acceptance into renowned institutions and her involvement in vital research projects underline her credibility and expertise in pediatric neurology.

💪 Impact and Influence

Beyond her clinical and academic contributions, Dr. Kollia has actively participated in voluntary medical programs, extending her expertise to underserved populations. She contributed to emergency case observations at the Children’s Hospital “Agia Sophia” and participated in medical landing programs in remote islands, showcasing her dedication to public health. Her influence extends to mentoring young medical professionals, sharing her knowledge, and contributing to the medical community’s growth.

💡 Legacy and Future Contributions

With a passion for advancing pediatric neurology, Dr. Kollia continues to shape the future of medical research and patient care. Her work in understanding movement disorders in children with epileptic encephalopathy holds the potential to improve diagnostic and therapeutic approaches in pediatric neurology. As she progresses in her career, her contributions to both clinical practice and scientific research will undoubtedly leave a lasting impact on the medical community and the lives of the children she treats.

 

Publication

  • Title: The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center
    Authors: V Zouvelou, D Yubero, L Apostolakopoulou, E Kokkinou, M Bilanakis, …
    Year: 2019

 

  • Title: MOTOR PHENOTYPING IN A GREEK COHORT OF PATIENTS WITH NEONATAL AND INFANTILE ONSET DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
    Authors: E Kollia, E Kokkinou, C Outsika, G Koltsida, V Zouvelou, A Vontzalidis, …
    Year: 2025

 

🌟 Conclusion

Ms. Kollia’s journey exemplifies the perfect blend of academic excellence, professional expertise, and compassionate patient care. Through her research and clinical endeavors, she continues to advance the understanding and treatment of pediatric neurological disorders. Her unwavering dedication to improving children’s health positions her as a leading figure in pediatric medicine. With her vision for excellence and continued contributions, she is set to leave a lasting impact on the medical field, inspiring future generations of healthcare professionals.

Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr.Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr. Hamid khan Icahn School of Medicine at Mount Sinai, New York Pakistan

Hamid Khan is a dedicated researcher and educator who recently completed his PhD in Biotechnology, specializing in Human Molecular Genetics. His academic journey includes a strong foundation in biological sciences, evidenced by his educational background ranging from a BSc to a PhD, with a focus on genetic analysis of rare congenital disorders. His doctoral research has provided insights into the genetic basis of autism spectrum disorder (ASD) and oculocutaneous albinism, contributing significantly to the understanding of these conditions.

profile

scholar

🎓 Education

PhD in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan & University of Toronto, Canada (2018-2024).MS/M.Phil in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan (2016-2018).M.Sc in ZoologyHazara University Mansehra, KPK, Pakistan (2011-2013).B.Sc in Biological Science (Botany, Zoology, Chemistry)University of Peshawar, Pakistan (2008-2010).H.S.S.C Pre-Medical
Peshawar Board, Pakistan (2006-2008)S.S.C Science SubjectsPeshawar Board, Pakistan (2004-2006).B.Ed in Education
Sarhad University of Science & Information Technology (2014).CT Certified TeacherAllama Iqbal Open University (2016).

🔬 Research Experience

Researcher at Biomolecular Genetic Engineering Lab, International Islamic University Islamabad (4 years).Research Associate in Pak-US Science and Technology Cooperation Program (1 year).Researcher in MiND Laboratory, Campbell Family Mental Health Research Institute, Toronto, Canada (6 months)

💼 Work Experience

Visiting Lecturer at Department of Biological Sciences, IIUI (3 years).Lecturer at IQRA College of Technology, IIUI (2 years)

 

🛠️ Skills

Laboratory Skills: PCR, NGS data analysis, Microarray, Gene Cloning, Cell Culturing, etc.Computer Skills: Python, Sentieon, Verseq, Exomiser, Excel, PowerPoint, Word.

🏆 Awards

IRSIP Award from the Higher Education Commission (HEC) Pakistan.First position holder in PhD coursework.Selected as Research Associate in a Pak-US project.

🌍 Collaborations

Currently working with three international and several national collaborations.

📚 Publications

  1. Title: Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
    Authors: Hamid Khan, Ricardo Harripaul, Anna Mikhailov, Sumayah Herzi, …
    Year: 2024

 

  1. Title: Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
    Authors: Lettie E Rawlins, Reza Maroofian, Stuart J Cannon, Muhannad Daana, Mina Zamani, Shamsul Ghani, …
    Year: 2024

 

  1. Title: Nigella sativa extract abrogates traumatic brain injury-induced memory impairment in adult mice
    Authors: RU Khan, SM Jawad, MM Kiyani, SA Shah, S Bashir, Hamid Khan
    Year: 2024

 

  1. Title: Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
    Authors: J Khan, S Asif, S Ghani, Hamid Khan, MW Arshad, SA Khan, S Lin, EL Baple, …
    Year: 2024

 

  1. Title: An Update on Recent Advancement in Autism Spectrum Disorder Treatment Strategies
    Authors: Hamid Khan, M Uzair, H Riaz, B Khan, MI Shabbir
    Year: 2023

Conclusion

Hamid Khan’s profile illustrates a strong commitment to advancing the field of biotechnology through research and education. His focus on the genetic underpinnings of rare disorders positions him as a valuable contributor to both academic and clinical settings. With a proven track record of research publications and collaborative projects, he is poised to make significant impacts in the realm of human genetics and molecular biology. His dedication to teaching and nurturing student curiosity further underscores his potential as an educator and mentor. As he seeks new opportunities, his combination of technical expertise, research experience, and passion for education will undoubtedly enable him to excel and inspire in any dynamic academic or research environment.